Holding(s) in Company

Marlowe

31/03/2025 14:53

RNS Number : 9755C

Marlowe PLC

31 March 2025

 

31 March 2025

Marlowe plc

 

Holding(s) in Company

 

Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that it has today been notified, in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules and as a result of the repurchase and cancellation by the Company of Ordinary Shares in accordance with the terms of Marlowe's buyback programme announced on 22 May 2024,  that Lord Michael Ashcroft KCMG PC, Interim Non-Executive Chairman of Marlowe, crossed a notifiable threshold in his percentage shareholding of ordinary shares of 50 pence each in the Company ("Ordinary Shares") on 31 March 2025.

Lord Ashcroft PCMG PC remains beneficially interested in an unchanged 15,310,170 Ordinary Shares, now representing 19.03 per cent. of the Group's issued ordinary share capital.

For further information please contact:

Marlowe plc
Lord Ashcroft, Interim Non-Executive Chair
www.marloweplc.com
Adam Councell, Chief Financial Officer
Tel: +44 (0)20 3813 8498
Benjamin Tucker, Head of Group Reporting
IR@marloweplc.com
Cavendish Capital Markets Limited (Nominated Adviser & Broker)
Ben Jeynes
Tel: +44 (0)20 7220 0500
George Lawson
FTI Consulting
Nick Hasell
Tel: +44 (0)20 3727 1340
Alex Le May


About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
HOLPKDBPNBKDBNN